文献速递心脑血管急症消化、代谢与肾脏急症

70-100岁人群LDL胆固醇升高与心肌梗死及动脉粥样硬化性心血管疾病风险增加:当代一级预防队列研究

Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort.
PubMed 文献 · Lancet · 2020-11-10
一句话结论在当代一级预防队列中,70-100岁人群LDL胆固醇升高者心肌梗死和动脉粥样硬化性心血管疾病绝对风险最高,5年NNT最低。

70-100岁人群绝对事件率最高,若全部给予中等强度他汀,5年预防一例事件的NNT最低。作者认为这对70-100岁人群的一级预防策略具有重要意义。

要点

  • 若全部给予中等强度他汀,5年预防一例心肌梗死或动脉粥样硬化性心血管疾病事件的NNT在70-100岁人群最低,且随年龄降低而升高。
  • 该研究支持在70-100岁一级预防人群中重视LDL胆固醇升高,以降低心肌梗死和动脉粥样硬化性心血管疾病负担。

适用人群与场景

  • 纳入:哥本哈根普通人群研究(CGPS)中20-100岁个体,基线无动脉粥样硬化性心血管疾病或糖尿病,且未服用他汀。
  • 排除:基线有动脉粥样硬化性心血管疾病或糖尿病者,以及正在服用他汀者。
  • 场景:一级预防人群,非急诊或ICU场景。

诊断标准与关键阈值

  • LDL胆固醇采用标准医院检测方法测量。

处置流程与药物剂量

  • 原文未提及具体他汀药物剂量、给药途径、频次或治疗目标值。
  • 原文仅提及在NNT估算中假设全部给予中等强度他汀,但未指定具体药物方案。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:当代前瞻性一级预防队列研究(哥本哈根普通人群研究,CGPS),单中心人群队列。
  • NNT:若全部给予中等强度他汀,5年预防一例心肌梗死或动脉粥样硬化性心血管疾病事件的NNT在70-100岁人群最低,随年龄降低而升高。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:前瞻性人群队列研究(一级预防队列)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心人群队列(哥本哈根普通人群研究),观察性设计,可能存在残余混杂;原文未提及随机化或盲法。

对床旁实践的改变

  • 对70-100岁一级预防人群,LDL胆固醇升高提示心肌梗死和动脉粥样硬化性心血管疾病绝对风险最高,应重视风险评估。
  • 该人群若给予中等强度他汀,5年NNT最低,支持考虑他汀一级预防,但具体药物剂量和方案原文未提及。
  • 不适用于基线已有动脉粥样硬化性心血管疾病或糖尿病者,也不适用于正在服用他汀者。
  • 常见陷阱:不能将观察性队列的HR直接作为个体治疗决策阈值,NNT为模型估算,需结合个体情况。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Findings of historical studies suggest that elevated LDL cholesterol is not associated with increased risk of myocardial infarction and atherosclerotic cardiovascular disease in patients older than 70 years. We aimed to test this hypothesis in a contemporary population of individuals aged 70-100 years.

METHODS: We included in our analysis individuals (aged 20-100 years) from the Copenhagen General Population Study (CGPS) who did not have atherosclerotic cardiovascular disease or diabetes at baseline and who were not taking statins. Standard hospital assays were used to measure LDL cholesterol. We calculated hazard ratios (HRs) and absolute event rates for myocardial infarction and atherosclerotic cardiovascular disease, and we estimated the number needed to treat (NNT) in 5 years to prevent one event.

FINDINGS: Between Nov 25, 2003, and Feb 17, 2015, 91 131 individuals were enrolled in CGPS. During mean 7·7 (SD 3·2) years of follow-up (to Dec 7, 2018), 1515 individuals had a first myocardial infarction and 3389 had atherosclerotic cardiovascular disease. Risk of myocardial infarction per 1·0 mmol/L increase in LDL cholesterol was augmented for the overall population (HR 1·34, 95% CI 1·27-1·41) and was amplified for all age groups, particularly those aged 70-100 years. Risk of atherosclerotic cardiovascular disease was also raised per 1·0 mmol/L increase in LDL cholesterol overall (HR 1·16, 95% CI 1·12-1·21) and in all age groups, particularly those aged 70-100 years. Risk of myocardial infarction was also increased with a 5·0 mmol/L or higher LDL cholesterol (ie, possible familial hypercholesterolaemia) versus less than 3·0 mmol/L in individuals aged 80-100 years (HR 2·99, 95% CI 1·71-5·23) and in those aged 70-79 years (1·82, 1·20-2·77). Myocardial infarction and atherosclerotic cardiovascular disease events per 1000 person-years for every 1·0 mmol/L increase in LDL cholesterol were highest in individuals aged 70-100 years, with number of events lower with younger age. The NNT in 5 years to prevent one myocardial infarction or atherosclerotic cardiovascular disease event if all people were given a moderate-intensity statin was lowest for individuals aged 70-100 years, with the NNT increasing with younger age.

INTERPRETATION: In a contemporary primary prevention cohort, people aged 70-100 years with elevated LDL cholesterol had the highest absolute risk of myocardial infarction and atherosclerotic cardiovascular disease and the lowest estimated NNT in 5 years to prevent one event. Our data are important for preventive strategies aimed at reducing the burden of myocardial infarction and atherosclerotic cardiovascular disease in the growing population aged 70-100 years.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet. 2020. PMID: 33186534. doi:10.1016/S0140-6736(20)32233-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。